EUDA Health Holdings Limited (NASDAQ:EUDA) Sees Significant Drop in Short Interest

EUDA Health Holdings Limited (NASDAQ:EUDA) was the target of a significant decrease in short interest in the month of September. As of September 15th, there was short interest totaling 1,589 shares, a decrease of 38.0% from the August 31st total of 2,561 shares. Based on an average trading volume of 41,368 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.1% of the company’s shares are short sold.

EUDA Health Trading Up 8.4%

EUDA stock opened at $17.24 on Friday. EUDA Health has a twelve month low of $5.26 and a twelve month high of $86.00. The business’s fifty day simple moving average is $15.64 and its two-hundred day simple moving average is $13.76.

EUDA Health (NASDAQ:EUDA) last issued its earnings results on Tuesday, September 29th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.57). The firm had revenue of $1.73 million for the quarter, compared to analysts’ expectations of $9.61 million.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of EUDA Health in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $55.00.

About EUDA Health

EUDA Health Holdings Limited is a digital health company focused on using technology to improve access to healthcare services. The company operates through subsidiaries and develops digital platforms intended to connect patients with healthcare providers and support the delivery of healthcare services.

Its activities include telemedicine and other technology-enabled healthcare solutions, such as facilitating virtual consultations, healthcare appointments and related services. EUDA has also pursued artificial-intelligence applications in sexual health, including technology designed to support the assessment of certain male sexual-health conditions.

The company is based in Singapore and has focused its operations on the Southeast Asian healthcare market.